Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Multi-proteomic analyses provide evidence for origin of a co-existing serum monoclonal gammopathy in CLL/MBL

Blood (2025) 146 (Supplement 1): 7408.

https://doi.org/10.1182/blood-2025-7408

Published: 2025

Journal Articles

Other cancers in patients with chronic lymphocytic leukemia/SMALL lymphocytic lymphoma

Helen Ma, Kari Rabe, Edward Ratner, Samuel Kosydar, Roberta Santos Azevedo, Pankaj Gupta, Susan O'Brien, Paul Hampel, Lindsey Roeker, Yucai Wang, Susan Slager, Sameer Parikh, Alessandra Ferrajoli

Blood (2025) 146 (Supplement 1): 4529.

https://doi.org/10.1182/blood-2025-4529

Published: 2025

Journal Articles

Oral azacitidine as maintenance therapy post allogeneic stem cell transplant in patients with myeloid malignancies

Michelle Nwachukwu, Wei-Ying Jen, Jeremy Ramdial, Caitlin Rausch, Roberta Santos Azevedo, Gautam Borthakur, Courtney DiNardo, Naval Daver, Betul Oran, Richard Champlin, Elizabeth Shpall, Guillermo Garcia-Manero, Farhad Ravandi, Tapan Kadia

Blood (2025) 146 (Supplement 1): 6975.

https://doi.org/10.1182/blood-2025-6975

Published: 2025

Journal Articles

Nodal progression in CLL: Real-world predictors of richter transformation and identification of a distinct high-risk NP-CLL subgroup

Nathalie Javidi-Sharifi, Sobana Balasubramanian, Hannah Lee, Paulina Predko, Svitlana Tyekucheva, Amber Mitchell, Stacey Fernandes, Roberta Santos Azevedo, Erin Parry, Catherine Wu, Matthew S Davids, Jennifer Brown

Blood (2025) 146 (Supplement 1): 5682.

https://doi.org/10.1182/blood-2025-5682

Published: 2025

Journal Articles

Impact of Reduced-Dose of Post-Transplantation Cyclophosphamide (PTCy) in HLA-Identical and Haploidentical Hematopoietic Stem Cell Transplantation: A Retrospective Analysis

Thais Fernanda Negrão de Araujo, Luana Pompeu dos Santos Rocha, Camila Frade de Oliveira, Camila de Fatima de Morais Ferreira, Breno Aires de Souza, Matheus Lopes Puls, Fernanda Santos Azevedo, Roberta Santos Azevedo, Pedro Henrique Arruda de Moraes, Vinicius Campos de Molla, Eurides L. Rosa, Caina Dabbous Liz, Caio Cesar Justino, Ana Marcela Fonseca, Roberta Shcolnik Szor, Celso Arrais-Rodrigues

Blood (2024) 144 (Supplement 1): 7324.

https://doi.org/10.1182/blood-2024-211512

Published: 2024

Journal Articles

Survival Benefits of Complete Cytogenetic Response in Patients with Newly Diagnosed Myelodysplastic Syndrome

Roberta Santos Azevedo, Hagop M. Kantarjian, Elias Jabbour, Rashmi Kanagal-Shamanna, Kelly S. Chien, Danielle Hammond, Samuel Urrutia, Carlos E. Bueso-Ramos, Keyur P. Patel, Guillermo Montalban-Bravo, Nicholas J. Short, Naval Daver, Gautam Borthakur, Tapan M. Kadia, William G. Wierda, Guillermo Garcia-Manero, Koji Sasaki

Blood (2024) 144 (Supplement 1): 6727.

https://doi.org/10.1182/blood-2024-201864

Published: 2024

Journal Articles

Clonal Evolution during Dual B Cell Receptor Pathway Inhibitor Therapy with Acalabrutinib and Umbralisib in CLL Patients

Saurabh Yadav, Sumbul Jawed Khan, Binu Kandathilparambil Sasi, Elizabeth F. Cohen, Kiyomi Mashima, Hannah Cormier, Stacey M. Fernandes, Samantha J. Shupe, Roberta Santos Azevedo, Mariia Mikhaleva, Philippe Armand, David C. Fisher, Matthew S. Davids, Inhye E. Ahn, Michael Y. Tolstorukov, Mark A. Murakami, Jennifer R. Brown

Blood (2024) 144 (Supplement 1): 4611.

https://doi.org/10.1182/blood-2024-207527

Published: 2024

Journal Articles

First-Line Treatment Choice and Risk of Other Malignancies in US Veterans Diagnosed with Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

Helen Ma, Sameer A. Parikh, Roberta Santos Azevedo, Susan M. O'Brien, Pankaj Gupta, Alessandra Ferrajoli

Blood (2024) 144 (Supplement 1): 5038.

https://doi.org/10.1182/blood-2024-207780

Published: 2024

Journal Articles

Impact of Allogeneic Hematopoietic Stem Cell Transplantation on Acute Myeloid Leukemia Patients without Complete Remission

Fernanda Santos Azevedo, Vinicius Campos de Molla, Roberta Shcolnik Szor, Pedro Henrique Arruda de Moraes, Eurides L. Rosa, Caio Cesar Justino, Cainã Dabbous Liz, Roberta Santos Azevedo, Ana Marcela Fonseca, Celso Arrais-Rodrigues

Blood (2024) 144 (Supplement 1): 7405.

https://doi.org/10.1182/blood-2024-212170

Published: 2024

Journal Articles

Feasibility and Efficacy of a Second Allogeneic Stem Cell Transplant for Acute Leukemias and Myelodysplastic Syndromes: Experience from Two Centers in São Paulo, Brazil

Eurides L. Rosa, Vinicius Campos de Molla, Caio Cesar Justino, Pedro Henrique Arruda de Moraes, Fernanda Santos Azevedo, Roberta Santos Azevedo, Caina Dabbous Liz, Roberta Shcolnik Szor, Celso Arrais-Rodrigues

Blood (2024) 144 (Supplement 1): 7415.

https://doi.org/10.1182/blood-2024-210409

Published: 2024

Journal Articles

Older Age and TP53 Mutations Are Predictors for the Development of Therapy-Related Myeloid Neoplasms in Adults Undergoing Frontline Therapy for Acute Lymphoblastic Leukemia

Roberta Santos Azevedo, Hagop M. Kantarjian, Koichi Takahashi, Cedric Christophe Nasnas, Sanam Loghavi, Nitin Jain, Fadi G. Haddad, Jayastu Senapati, Ghayas C. Issa, Hussein A. Abbas, Tapan M. Kadia, Kelly S. Chien, Guillermo Montalban-Bravo, Rebecca Garris, Farhad Ravandi, Elias Jabbour, Nicholas J. Short

Blood (2024) 144 (Supplement 1): 728.

https://doi.org/10.1182/blood-2024-207745

Published: 2024

Journal Articles

Complex Karyotype, but Not Isolated TP53 mutation, Predicts Overall Survival in Chronic Lymphocytic Leukemia Patients in the Era of Targeted Therapy

Roberta Santos Azevedo, Mariia Mikhaleva, Kiyomi Mashima, Stephen Martindale, Stacey M. Fernandes, Svitlana Tyekucheva, Inhye E. Ahn, Matthew S. Davids, Jennifer R. Brown

Blood (2024) 144 (Supplement 1): 583.

https://doi.org/10.1182/blood-2024-206576

Published: 2024

Journal Articles

Investigating the Influence of Germline ATM Variants on Susceptibility to Chronic Lymphocytic Leukemia and Other Malignancies

Roberta Santos Azevedo, Francesca Morelli, Kiyomi Mashima, Rayan Fardoun, Svitlana Tyekucheva, Stacey M Fernandes, Samantha J. Shupe, Marissa Terra, Anisha Patel, Joseph Yu, Jennifer R. Brown

Blood (2023) 142 (Supplement 1): 3266.

https://doi.org/10.1182/blood-2023-180136

Published: 2023

Journal Articles

Understanding Resistance Mechanisms and Growth Kinetics of CLL Treated with Covalent and Non-Covalent BTK Inhibitors

Aishath Naeem, Liang Li, Filippo Utro, Justin Cha, Junko Tsuji, Stacey M Fernandes, Roberta Santos Azevedo, Francesca Morelli, Zunqiu Wang, Samantha J. Shupe, Kahn Rhrissorrakrai, Chaya Levovitz, Brian P Danysh, Alexandria Kluge, Matthew S Davids, Ignaty Leshchiner, Laxmi Parida, Gad Getz, Jennifer R. Brown

Blood (2023) 142 (Supplement 1): 4623.

https://doi.org/10.1182/blood-2023-186052

Published: 2023

Journal Articles

Comparison between Post-Transplant Cyclophosphamide Use and Conventional Prophylaxis of Graft-Versus-Host Disease: A Retrospective Study

Caio Branício Prato, Caio Cesar Justino, Ana Paula Tavares, Rayana Bomfim Leonel, Pedro Henrique Arruda de Moraes, Ana Marcela Fonseca, Roberta Santos Azevedo, Vinicius Campos de Molla, Celso Arrais-Rodrigues

Blood (2023) 142 (Supplement 1): 7031.

https://doi.org/10.1182/blood-2023-190146

Published: 2023

Update search

NARROW

Publications

Format

Article Type

Date

Availability

Multi-proteomic analyses provide evidence for origin of a co-existing serum monoclonal gammopathy in CLL/MBL

Other cancers in patients with chronic lymphocytic leukemia/SMALL lymphocytic lymphoma

Oral azacitidine as maintenance therapy post allogeneic stem cell transplant in patients with myeloid malignancies

Nodal progression in CLL: Real-world predictors of richter transformation and identification of a distinct high-risk NP-CLL subgroup

Impact of Reduced-Dose of Post-Transplantation Cyclophosphamide (PTCy) in HLA-Identical and Haploidentical Hematopoietic Stem Cell Transplantation: A Retrospective Analysis

Survival Benefits of Complete Cytogenetic Response in Patients with Newly Diagnosed Myelodysplastic Syndrome

Clonal Evolution during Dual B Cell Receptor Pathway Inhibitor Therapy with Acalabrutinib and Umbralisib in CLL Patients

First-Line Treatment Choice and Risk of Other Malignancies in US Veterans Diagnosed with Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

Impact of Allogeneic Hematopoietic Stem Cell Transplantation on Acute Myeloid Leukemia Patients without Complete Remission

Feasibility and Efficacy of a Second Allogeneic Stem Cell Transplant for Acute Leukemias and Myelodysplastic Syndromes: Experience from Two Centers in São Paulo, Brazil

Older Age and TP53 Mutations Are Predictors for the Development of Therapy-Related Myeloid Neoplasms in Adults Undergoing Frontline Therapy for Acute Lymphoblastic Leukemia

Complex Karyotype, but Not Isolated TP53 mutation, Predicts Overall Survival in Chronic Lymphocytic Leukemia Patients in the Era of Targeted Therapy

Investigating the Influence of Germline ATM Variants on Susceptibility to Chronic Lymphocytic Leukemia and Other Malignancies

Understanding Resistance Mechanisms and Growth Kinetics of CLL Treated with Covalent and Non-Covalent BTK Inhibitors

Comparison between Post-Transplant Cyclophosphamide Use and Conventional Prophylaxis of Graft-Versus-Host Disease: A Retrospective Study

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only